Autologous adipose-derived mesenchymal stem cells (Medical University of Warsaw)

N/A

Report date: 2023/01/12 15:31:33

Base Information

Drug NameAutologous adipose-derived mesenchymal stem cells (Medical University of Warsaw)

Drug Alias Nameautologous ADSC stem cellsautologous ADSC

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsDiabetic FootOsteoarthritis, KneeOsteoarthritis, Hip +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPoland

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMedical University Of Warsaw

China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of Warsaw

Inactive CompaniesN/A

Active IndicationsDiabetic Foot

Inactive IndicationsOsteoarthritis, KneeOsteoarthritis, HipOsteoarthritis

Other Information

ATC CodeN/A